David Kaminetzky
- Co-authors
- Ruoqian ShenMakoto SumitomoDavid M. NanusAkira IwaseDaniel NavarroMaria‐Magdalena GeorgescuRong ZhengJasmine Zain
- Topics
- Multiple Myeloma Research and Treatments (11 papers)Peptidase Inhibition and Analysis (4 papers)Protein Degradation and Inhibitors (3 papers)
- Cited by
- Internal MedicineHematologyOncology
- Journals
- BloodNeurologyCancer Cell
- Partner nations
- United StatesUnited KingdomNorway
In The Last Decade
David Kaminetzky
16 papers receiving 301 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 157
- Oncology 111
- Pulmonary and Respiratory Medicine 62
- Hematology 58
- Infectious Diseases 40
Countries citing papers authored by David Kaminetzky
This map shows the geographic impact of David Kaminetzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kaminetzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kaminetzky more than expected).
Fields of papers citing papers by David Kaminetzky
This network shows the impact of papers produced by David Kaminetzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kaminetzky. The network helps show where David Kaminetzky may publish in the future.
Co-authorship network of co-authors of David Kaminetzky
This figure shows the co-authorship network connecting the top 25 collaborators of David Kaminetzky. A scholar is included among the top collaborators of David Kaminetzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kaminetzky. David Kaminetzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 11 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 17 | |
| 8 | 10 | |
| 9 | 0 | |
| 10 | 25 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 48 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 5 | |
| 17 | 6 | |
| 18 | 24 | |
| 19 | 93 | |
| 20 | 50 |
About David Kaminetzky
David Kaminetzky is a scholar working on Hematology, Oncology and Internal Medicine, having authored 20 papers that have together received 303 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Peptidase Inhibition and Analysis (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Internal Medicine (24 citations), Hematology (58 citations) and Oncology (111 citations). David Kaminetzky has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Ruoqian Shen, Makoto Sumitomo, David M. Nanus, Akira Iwase, Daniel Navarro, Maria‐Magdalena Georgescu, Rong Zheng, Jasmine Zain, Owen A. O’Connor and Kerry L. Burnstein. Their work appears in journals such as Blood, Neurology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.